Top Pharma Companies & Drugs in 2024: Merck’s Keytruda maintains top spot as Novo’s semaglutide nips at its heels

Data Compilation
#PharmaFlow

Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

Stock Recap
#PipelineProspector

Seloken ZOC

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

56 API Suppliers, 34 USDMF, 16 CEP/COS, 13 EU WC, 18 NDC API, 27 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

184 FDF Dossiers, 95 FDA Orange Book, 30 Europe, 27 Australia, 32 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 6 Evonik, 2 Rochem International Inc, 6 SPI Pharma, 13 DKSH, 6 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 5 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Pramukh Pharmachem, 1 Zeal MediPharma, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 30 BASF, 1 Clariant, 15 Corel Pharma Chem, 5 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 13 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 32 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 21 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 4 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

77 Fillers, Diluents & Binders, 73 Coating Systems & Additives, 43 Controlled & Modified Release, 42 Thickeners and Stabilizers, 38 Solubilizers, 33 Disintegrants & Superdisintegrants, 29 Direct Compression, 27 Granulation, 23 Lubricants & Glidants, 23 Film Formers & Plasticizers, 17 Topical, 16 Taste Masking, 13 Co-Processed Excipients, 12 Parenteral, 11 Rheology Modifiers, 11 Chewable & Orodispersible Aids, 9 Emulsifying Agents, 9 Empty Capsules, 5 Coloring Agents, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

DIGITAL CONTENT

32 News #PharmaBuzz

32 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 12 Regulatory FDF Prices

MARKET PLACE

9 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 1 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
25/04/2025	Moehs Iberica	Spain	Moehs Iberica S.L. Rubi ES	CEP 2004-202 - Rev 07	Metoprolol succinate	2024-02-27	Valid	Chemical		1448
25/04/2025	Arevipharma	Germany	AREVIPHARMA GMBH Radebeul DE	R1-CEP 2005-223 - Rev 00	Metoprolol succinate	2013-02-05	Withdrawn by Holder	Chemical	2017-08-24	1448

Seloken ZOC

Seloken ZOC

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

56 API Suppliers

34 USDMF

16 CEP/COS

13 EU WC

18 NDC API

27 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

184 FDF Dossiers

95 FDA Orange Book

30 Europe

27 Australia

32 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE

TABLET, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE

TABLET, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE

TABLET, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

6 Evonik

2 Rochem International Inc

6 SPI Pharma

13 DKSH

6 Faran Shimi Pharmaceutical

5 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

5 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 Pramukh Pharmachem

1 Zeal MediPharma

4 ACG Worldwide

7 Actylis

1 Aeon Procare

3 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Ashland

30 BASF

1 Clariant

15 Corel Pharma Chem

5 DFE Pharma

2 Finar

12 Gangwal Chemicals

13 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

32 Kerry

5 Kima Chemical

6 Lonza Capsugel

17 Microlex e.U

2 Nanjing Bold Chemical

1 NEWEDGE Overseas

2 Nomisma Healthcare

3 Novo Excipients

4 Pharmatrans-Sanaq

6 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

21 Roquette

14 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons